by synergycap1 | May 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Technology, Working Capital
The WannaCry ransomeware that’s swept through nearly a quarter million computers worldwide, encrypting valuable data and demanding payment before it is decrypted, was likely created by native Chinese speakers, according to new research by the cybersecurity firm...
by synergycap1 | May 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
SINGAPORE (Reuters) – U.S. crude oil prices rose toward $50 per barrel on Tuesday as a strong start to the summer driving season in the United States suggested strong fuel demand in months ahead.
by synergycap1 | May 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Singapore’s central bank on Tuesday said it has fined Credit Suisse and United Overseas Bank (UOB) for breaches relating to the scandal-hit Malaysian sovereign wealth fund 1Malaysia Development Berhad (1MDB). The Monetary Authority of Singapore (MAS) said in a...
by synergycap1 | May 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Non-Bank Loans, Working Capital
By DANIEL VICTOR May 29, 2017 Frank Deford, who mined the sports world for human stories and told them with literary grace over six decades in Sports Illustrated, a shelf of books and many years of radio and television commentary, died on Sunday at his home...
by synergycap1 | May 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
TOKYO (Reuters) – The dollar firmed on Tuesday, taking back ground against the euro and sterling which were pressured by political uncertainties in the UK and eurozone.
by synergycap1 | May 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Bills seeking to rein in the cost of prescription drugs include proposals to speed approval of generic drugs and allow the importing of cheaper drugs.
